medicaid approved glp 1 US states drop coverage of GLP-1 weight-loss drugs as demand rises | US healthcare Does Medicaid Cover GLP-1 Drugs?

The study surveyed 264 real weight loss patients

The share of the public who report having heard about these drugs has increased since July 2023 when seven in ten adults reported having heard at least a little about these drugs and one in five (19%) said they had heard a lot. The share who say they have heard a lot about these drugs rises to at least four in ten among those who have ever been told by a doctor that they have diabetes (45%) or heart disease (41%) or have been told by a doctor in the past five years that they are overweight or obese (42%) the primary conditions these drugs are prescribed for

Effectiveness: For patients without co-morbid depression or contraindications, Adderall and other stimulants usually provide a stronger and more immediate reduction in ADHD symptoms, with duration of effect lasting several hours, depending on the particular version of stimulant

People who have very little weight loss may still get real benefit for treating cardiovascular and liver disease, sleep apnea, and a range of inflammatory and neurological diseases